Showing results (201-210 of 218) with videos related to

Sort By:
Pageof 22
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|February 28, 2022
Predictive Value of Preoperative Endoscopic Ultrasound (EUS) After Neoadjuvant Chemotherapy in Locally Advanced Esophagogastric Cancer - Data From a Randomized German Phase II TrialVisvakanth Sivanathan, Christoph Utz, Thomas Thomaidis, et al.
Onkologie|September 22, 2011
Cancer patients and the Internet: a survey of the 'Quality of Life' Working Groups of the Arbeitsgemeinschaft für Internistische Onkologie and the Nord-Ostdeutsche Gesellschaft für Gynäkologische OnkologieDeniz Gencer, Felix Tauchert, Nina Keilhauer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2025
Adjuvant Aspirin Treatment in PIK3CA Mutated Colon Cancer Patients: The SAKK 41/13 - Prospective Randomized Placebo-Controlled Double-Blind TrialUlrich Güller, Stefanie Hayoz, Daniel Horber, et al.
JAMA Network Open|January 23, 2024
Ramucirumab, Avelumab, and Paclitaxel as Second-Line Treatment in Esophagogastric Adenocarcinoma: The Phase 2 RAP (AIO-STO-0218) Nonrandomized Controlled TrialPeter Thuss-Patience, Anica Högner, Eray Goekkurt, et al.
BMC Cancer|June 19, 2023
Ramucirumab plus irinotecan / leucovorin / 5-FU versus ramucirumab plus paclitaxel in patients with advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction, who failed one prior line of palliative chemotherapy: the phase II/III RAMIRIS study (AIO-STO-0415)Sylvie Lorenzen, Alix Schwarz, Claudia Pauligk, et al.
European Journal of Cancer (Oxford, England : 1990)|March 5, 2018
Perioperative chemotherapy with or without epidermal growth factor receptor blockade in unselected patients with locally advanced oesophagogastric adenocarcinoma: Randomized phase II study with advanced biomarker program of the German Cancer Society (AIO/CAO STO-0801)Michael Stahl, Annett Maderer, Florian Lordick, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|October 17, 2023
German, Austrian, and Swiss guidelines for systemic treatment of gastric cancerFlorian Lordick, Salah-Eddin Al-Batran, Dirk Arnold, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|September 7, 2014
International comparison of the German evidence-based S3-guidelines on the diagnosis and multimodal treatment of early and locally advanced gastric cancer, including adenocarcinoma of the lower esophagusMarkus Moehler, Christoph T H Baltin, Matthias Ebert, et al.
Nature Communications|October 24, 2023
Nivolumab and ipilimumab in recurrent or refractory cancer of unknown primary: a phase II trialMaria Pouyiourou, Bianca N Kraft, Timothy Wohlfromm, et al.
BMC Cancer|March 1, 2020
High thromboembolic event rate in patients with locally advanced oesophageal cancer during neoadjuvant therapy. An exploratory analysis of the prospective, randomised intergroup phase III trial SAKK 75/08Martin Fehr, Hanne Hawle, Stefanie Hayoz, et al.
Pageof 22